loader
Home/
Journal of Global Vaccines R&D

Aabstract


Short Communication

HMGB1 Release by C5 a Anaphylatoxin is an Effective Target for Sepsis Treatment

Noriko Okada, Masaki Imai, Alan Okada, Fumiko Ono, Hidechika Okada

Correspondence Address :

Hidechika Okada
Choju Medical Institute
Fukushimura Hospital
Noyori-cho
Yamanaka 19-14, Toyohashi 441-8124
Japan
Email: hiokada@med.nagoya-cu.ac.jp

Received on: August 28, 2017, Accepted on: October 25, 2017, Published on: November 03, 2017

Citation: Hidechika Okada, Noriko Okada, Masaki Imai, Alan Okada, Fumiko Ono (2017). HMGB1 Release by C5 a Anaphylatoxin is an Effective Target for Sepsis Treatment

Copyright: 2017 Hidechika Okada et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Abstract

Abstract
Keywords: Complement, C5a, Anaphylatoxin, Inflammation, Sepsis, Peptide, Endotoxinshock, C5a receptor, C5L2, HMGB1, Cytokine storm